Opposite functions of histamine H1 and H2 receptors and H3 receptor in substantia nigra pars reticulata

Journal of Neurophysiology

Volumn 96, Issue 3, 2006, Pages 1581-1591

  Zhou, Fu Wen ^a   Xu, Jian Jun ^a   Zhao, Yu ^a   LeDoux, Mark S ^a   Zhou, Fu Ming ^a  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; HISTAMINE H1 RECEPTOR; HISTAMINE H2 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; CELL MEMBRANE DEPOLARIZATION; CONTROLLED STUDY; FEMALE; HISTAMINE RELEASE; HYPERPOLARIZATION; MALE; MOUSE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; SUBSTANTIA NIGRA; WHOLE CELL;

ANIMALS; BASAL GANGLIA; FEMALE; GAMMA-AMINOBUTYRIC ACID; HISTAMINE; MALE; MICE; MICE, INBRED C57BL; NEURONS; PATCH-CLAMP TECHNIQUES; RECEPTORS, HISTAMINE H1; RECEPTORS, HISTAMINE H2; RECEPTORS, HISTAMINE H3; SUBSTANTIA NIGRA;

EID: 33748565950     PISSN: 00223077     EISSN: None     Source Type: Journal    
DOI: 10.1152/jn.00148.2006     Document Type: Article

References (72)

1. Airaksinen MS and Panula P. The histaminergic system in the guinea pig central nervous system: an immunocytochemical mapping study using an antiserum against histamine. J Comp Neurol 273: 163-186, 1988.
2. 3 receptors in basal ganglia and frontal cortex of healthy controls and patients with Parkinson's disease. Neurobiol Dis 8: 707-716, 2001.
3. Anichtchik OV, Rinne JO, Kalimo H, and Panula P. An altered histaminergic innervation of the substantia nigra in Parkinson's disease. Exp Neurol 163: 20-30, 2000.
4. 3) of histamine receptor. Nature 302: 832-837, 1983.
5. Atherton JF and Bevan MD. Ionic mechanisms underlying autonomous action potential generation in the somata and dendrites of GABAergic substantia nigra pars reticulata neurons in vitro. J Neurosci 25: 8272-8281, 2005.
6. 2 histamine receptor-phosphorylation of Kv3.2 modulates interneuron fast spiking. Nat Neurosci 3: 791-798, 2000.
7. 1) receptor antagonists. Eur J Pharmacol 387: R5-R7, 2000.
8. 1 receptor mediated action. Br J Pharmacol 131: 1135-1142, 2000.
9. Bennett BD and Wilson CJ. Spontaneous activity of neostriatal cholinergic interneurons in vitro. J Neurosci 19: 5586-5596, 1999.
10. Bergman H, Feingold A, Nini A, Raz A, Slovin H, Abeles M, and Vaadia E. Physiological aspects of information processing in the basal ganglia of normal and parkinsonian primates. Trends Neurosci 21: 32-38, 1998.
11. Bonci A and Malenka RC. Properties and plasticity of excitatory synapses on dopaminergic and GABAergic cells in the ventral tegmental area. J Neurosci 19: 3723-3730, 1999.
12. 125I]iodobolpyramine. Neuroscience 26: 553-600, 1988.
13. Brown RE and Haas HL. On the mechanism of histaminergic inhibition of glutamate release in the rat dentate gyrus. J Physiol 515: 777-783, 1999.
14. Brown RE, Stevens DR, and Haas HL. The physiology of brain histamine. Prog Neurobiol 63: 637-672, 2001.
15. Cebrian C, Parent A, and Prensa L. Patterns of axonal branching of neurons of the substantia nigra pars reticulata and pars lateralis in the rat. J Comp Neurol 492: 349-369, 2005.
16. Celada P, Paladini CA, and Tepper JM. GABAergic control of rat substantia nigra dopaminergic neurons: role of globus pallidus and substantia nigra pars reticulata. Neuroscience 89: 813-825, 1999.
17. Chevalier G and Deniau JM. Disinhibition as a basic process in the expression of striatal functions. Trends Neurosci 13: 277-280, 1990.
18. Colquhoun D and Sakmann B. From muscle endplate to brain synapses: a short history of synapses and agonist-activated ion channels. Neuron 20: 381-387, 1998.
19. DeLong MR. Primate models of movement disorders of basal ganglia origin. Trends Neurosci 13: 281-285, 1990.
20. Deniau JM, Kitai ST, Donoghue JP, and Grofova I. Neuronal interactions in the substantia nigra pars reticulata through axon collaterals of the projection neurons. An electrophysiological and morphological study. Exp Brain Res 47: 105-113, 1982.
21. Diana M and Tepper JM. Electrophysiological pharmacology of mesencephalic dopaminergic neurons. In: Handbook of Experimental Pharmacology: Dopamine in the CNS, edited by Di Chiara G. Heidelberg, Germany: Springer-Verlag, 2002, p. 1-61.
22. Fallon JH and Loughlin SE. Substantia nigra. In: The Rat Nervous System, edited by Paxinos G. San Diego, CA: Academic Press, 1995, p. 215-237.
23. 3 agonist immepip and systemic apomorphine elicit ipsilateral turning behaviour in naive rats, but reduce contralateral turning in hemiparkinsonian rats. Behav Brain Res 154: 409-415, 2004.
24. Gomez-Ramirez J, Johnston TH, Visanji NP, Fox SH, and Brotchie JM. Histamine H3 receptor agonists reduce L-dopa-induced chorea, but not dystonia, in the MPTP-lesioned nonhuman primate model of Parkinson's disease. Mov Disord 21: 839-846, 2006.
25. Gorelova N and Reiner PB. Histamine depolarizes cholinergic septal neurons. J Neurophysiol 75: 707-714, 1996.
26. Grofova I, Deniau JM, and Kitai ST. Morphology of the substantia nigra pars reticulata projection neurons intracellularly labeled with HRP. J Comp Neurol 208: 352-368, 1982.
27. Gulley JM, Kosobud AE, and Rebec GV. Behavior-related modulation of substantia nigra pars reticulata neurons in rats performing a conditioned reinforcement task. Neuroscience 111: 337-349, 2002.
28. Haas H and Panula P. The role of histamine and the tuberomamillary nucleus in the nervous system. Nat Rev Neurosci 4: 121-130, 2003.
29. Haas HL and Konnerth A. Histamine and noradrenaline decrease calciumactivated potassium conductance in hippocampal pyramidal cells. Nature 302: 432-434, 1983.
30. Hikosaka O, Takikawa Y, and Kawagoe R. Role of the basal ganglia in the control of purposive saccadic eye movements. Physiol Rev 80: 953-978, 2000.
31. Hutchison WD, Dostrovsky JO, Walters JR, Courtemanche R, Boraud T, Goldberg J, and Brown P. Neuronal oscillations in the basal ganglia and movement disorders: evidence from whole animal and human recordings. J Neurosci 24: 9240-9243, 2004.
32. Ibanez-Sandoval O, Hernandez A, Floran B, Galarraga E, Tapia D, Valdiosera R, Erlij D, Aceves J, and Bargas J. Control of the subthalamic innervation of substantia nigra pars reticulata by D1 and D2 dopamine receptors. J Neurophysiol 95: 1800-1811, 2006.
33. Jang IS, Rhee JS, Watanabe T, Akaike N, and Akaike N. Histaminergic modulation of GABAergic transmission in rat ventromedial hypothalamic neurones. J Physiol 534: 791-803, 2001.
34. Juraska JM, Wilson CJ, and Groves PM. The substantia nigra of the rat: a Golgi study. J Comp Neurol 172: 585-600, 1977.
35. Katz B. The Release of Neural Transmitter Substances. Liverpool, UK: Liverpool Univ. Press, 1969.
36. Korotkova TM, Haas HL, and Brown RE. Histamine excites GABAergic cells in the rat substantia nigra and ventral tegmental area in vitro. Neurosci Lett 320: 133-136, 2002.
37. Lacey MG, Mercuri NB, and North RA. Two cell types in rat substantia nigra zona compacta distinguished by membrane properties and the actions of dopamine and opioids. J Neurosci 9: 1233-1241, 1989.
38. Mailly P, Charpier S, Menetrey A, and Deniau JM. Three-dimensional organization of the recurrent axon collateral network of the substantia nigra pars reticulata neurons in the rat. J Neurosci 23: 5247-5257, 2003.
39. Maurice N, Thierry AM, Glowinski J, and Deniau JM. Spontaneous and evoked activity of substantia nigra pars reticulata neurons during high-frequency stimulation of the subthalamic nucleus. J Neurosci 23: 9929-9936, 2003.
40. McCormick DA and Williamson A. Convergence and divergence of neurotransmitter action in human cerebral cortex. Proc Natl Acad Sci USA 86: 8098-8102, 1989.
41. McCormick DA and Williamson A. Modulation of neuronal firing mode in cat and guinea pig LGNd by histamine: possible cellular mechanisms of histaminergic control of arousal. J Neurosci 11: 3188-3199, 1991.
42. Motulsky H. Intuitive Biostatistics. New York: Oxford Univ. Press, 1995.
43. Nakanishi H, Kita H, and Kitai ST. Intracellular study of rat substantia nigra pars reticulata neurons in an in vitro slice preparation: electrical membrane properties and response characteristics to subthalamic stimulation. Brain Res 437: 45-55, 1987.
44. Nelson EL, Liang CL, Sinton CM, and German DC. Midbrain dopaminergic neurons in the mouse: computer-assisted mapping. J Comp Neurol 369: 361-371, 1996.
45. Nevet A, Morris G, Saban G, Fainstein N, and Bergman H. Discharge rate of substantia nigra pars reticulata neurons is reduced in non-parkinsonian monkeys with apomorphine-induced orofacial dyskinesia. J Neurophysiol 92: 1973-1981, 2004.
46. Obeso JA, Rodriguez-Oroz MC, Rodriguez M, Lanciego JL, Artieda J, Gonzalo N, and Olanow CW. Pathophysiology of the basal ganglia in Parkinson's disease. Trends Neurosci 23: S8-S19, 2000.
47. Panula P, Pirvola U, Auvinen S, and Airaksinen MS. Histamine- immunoreactive nerve fibers in the rat brain. Neuroscience 28: 585-610, 1989.
48. Parent A, Sato F, Wu Y, Gauthier J, Levesque M, and Parent M. Organization of the basal ganglia: the importance of axonal collateralization. Trends Neurosci 23: S20-S27, 2000.
49. Paxinos G and Franklin KBJ. The Mouse Brain in Stereotaxic Coordinates. San Diego, CA: Academic Press, 2001.
50. 3 receptor and its gene transcripts in rat brain. Neuroscience 114: 173-193, 2002.
51. Richards CD, Shiroyama T, and Kitai ST. Electrophysiological and immuno-cytochemical characterization of GABA and dopamine neurons in the substantia nigra of the rat. Neuroscience 80: 545-557, 1997.
52. Rinne JO, Anichtchik OV, Eriksson KS, Kaslin J, Tuomisto L, Kalimo H, Roytta M, and Panula P. Increased brain histamine levels in Parkinson's disease but not in multiple system atrophy. J Neurochem 81: 954-960, 2002.
53. Ryu JH, Yanai K, Sakurai E, Kim CY, and Watanabe T. Ontogenetic development of histamine receptor subtypes in rat brain demonstrated by quantitative autoradiography. Brain Res Dev Brain Res 87: 101-110, 1995.
54. 3 receptors in the striatum and substantia nigra after 6-hydroxydopamine-induced denervation of dopaminergic neurons: an autoradiographic study. Neurosci Lett 178: 19-22, 1994.
55. Schultz W. Activity of pars reticulata neurons of monkey substantia nigra in relation to motor, sensory, and complex events. J Neurophysiol 55: 660-677, 1986.
56. Schwartz JC and Arrang JM. Histamine. In: Neuropsychopharmacology: The Fifth Generation of Progress, edited by Davis KL, Charney D, Coyle JT, and Nemeroff C. Philadelphia, PA: Lippincott, Williams & Wilkins, 2002, p. 179-190.
57. Shen KZ and Johnson SW. Presynaptic GABAB and adenosine A1 receptors regulate synaptic transmission to rat substantia nigra reticulata neurons. J Physiol 505: 153-163, 1997.
58. 2 receptors. Proc Natl Acad Sci USA 93: 6802-6807, 1996.
59. Tepper JM, Martin LP, and Anderson DR. GABAA receptor-mediated inhibition of rat substantia nigra dopaminergic neurons by pars reticulata projection neurons. J Neurosci 15: 3092-3103, 1995.
60. 3 receptors inhibit serotonin release in substantia nigra pars reticulata. J Neurosci 24: 8704-8710, 2004.
61. 1 receptor. I. Gene cloning, characterization, and tissue expression revealed by in situ hybridization. J Neurochem 62: 507-518, 1994.
62. van der Goot H and Timmerman H. Selective ligands as tools to study histamine receptors. Eur J Med Chem 35: 5-20, 2000.
63. 2receptor and its gene transcripts in guinea-pig brain. Neuroscience 80: 321-343, 1997.
64. Walters JR, Ruskin DN, Allers KA, and Bergstrom DA. Pre- and postsynaptic aspects of dopamine-mediated transmission. Trends Neurosci 23: S41-S47, 2000.
65. Wichmann T, Bergman H, Starr PA, Subramanian T, Watts RL, and DeLong MR. Comparison of MPTP-induced changes in spontaneous neuronal discharge in the internal pallidal segment and in the substantia nigra pars reticulata in primates. Exp Brain Res 125: 397-409, 1999.
66. Wilson CJ. Basal ganglia. In: The Synaptic Organization of the Brain, edited by Shepherd GM. New York: Oxford Univ. Press, 2004, p. 361-413.
67. Wilson CJ, Young SJ, and Groves PM. Statistical properties of neuronal spike trains in the substantia nigra: cell types and their interactions. Brain Res 136: 243-260, 1977.
68. Yanovsky Y and Haas HL. Histamine increases the bursting activity of pyramidal cells in the CA3 region of mouse hippocampus. Neurosci Lett 240: 110-112, 1998.
69. Yung WH, Hausser MA, and Jack JJ. Electrophysiology of dopaminergic and non-dopaminergic neurones of the guinea-pig substantia nigra pars compacta in vitro. J Physiol 436: 643-667, 1991.
70. Zhou FM and Hablitz JJ. Morphological properties of intracellularly labeled rat neocortical layer I neurons. J Comp Neurol 376: 198-213, 1996.
71. Zhou FM and Hablitz JJ. Dopamine modulation of membrane and synaptic properties of interneurons in rat cerebral cortex. J Neurophysiol 81: 967-976, 1999.
72. Zhou FM, Liang Y, Salas R, Zhang L, De Biasi M, and Dani JA. Co-release of dopamine and serotonin from striatal dopamine terminals. Neuron 46: 65-74, 2005.